{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"Research Square"}],"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T01:56:12Z","timestamp":1762739772126,"version":"build-2065373602"},"posted":{"date-parts":[[2025,10,22]]},"group-title":"In Review","reference-count":57,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2025,10,20]]},"abstract":"<title>Abstract<\/title>\n                <p>\n                  <bold>Background:<\/bold>\n                  Type 2 diabetes mellitus (T2DM) is associated with increased risk for cognitive decline and diagnosis of Alzheimer\u2019s disease (AD). The mechanisms of T2DM related dementia remain unclear.\n                  <bold>Methods:<\/bold>\n                  Brain magnetic resonance imaging was retrospectively obtained for 1,802 adults (age 66 +\/- 9 years, 47% male) of whom N = 271 had T2DM. We applied an accelerated longitudinal design and imaging transcriptomics to non-invasively examine the group-level trajectories of\n                  <italic>PPARG<\/italic>\n                  and\n                  <italic>PRKAG2<\/italic>\n                  co-expression in gray matter.\n                  <bold>Results:<\/bold>\n                  Gene expression trajectories differed significantly between T2DM and controls (\u03c7\u00b2 = 13.82, p = 0.001). Co-expression was higher in early stages and then weakened in later stages among T2DM, while remaining stable over time in controls.\n                  <italic>PPARG<\/italic>\n                  and\n                  <italic>PRKAG2<\/italic>\n                  co-expression was significantly associated with cognitive function in controls (F = 3.17, p &lt; 0.001) but not T2DM (F = 7.72, p = 0.299) suggesting dysregulated or failed compensatory mechanisms. Individuals with T2DM not taking metformin demonstrated unstable gene co-expression over time compared to those taking metformin (\u03c7\u00b2 = 12.42, p = 0.006).\n                  <bold>Conclusions:<\/bold>\n                  The convergence of\n                  <italic>PPARG<\/italic>\n                  -mediated metabolic remodeling and\n                  <italic>PRKAG2<\/italic>\n                  \/AMPK-driven energy sensing may act as a coordinated neuroprotective mechanism, upregulated in response to cellular stress in both pathological (T2DM) and normative (aging) contexts. However, these processes appear to become dysregulated in T2DM, potentially resulting in cognitive decline and increased risk for dementia.\n                <\/p>","DOI":"10.21203\/rs.3.rs-7907793\/v1","type":"posted-content","created":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:02:27Z","timestamp":1761159747000},"source":"Crossref","is-referenced-by-count":0,"title":["Temporal dysregulation of PPARG-PRKAG2 co-expression in gray matter: Implications for cognitive decline and intervention targets in type 2 diabetes"],"prefix":"10.21203","author":[{"given":"Shelli R.","family":"Kesler","sequence":"first","affiliation":[{"name":"University of Texas at Austin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kimberly A.","family":"Lewis","sequence":"additional","affiliation":[{"name":"University of California Los Angeles"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather","family":"Cuevas","sequence":"additional","affiliation":[{"name":"University of Texas at Austin"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elena","family":"Flowers","sequence":"additional","affiliation":[{"name":"University of California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.3389\/fendo.2014.00161","article-title":"Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease","volume":"5","author":"Blazquez E","year":"2014","unstructured":"Blazquez E, Velazquez E, Hurtado-Carneiro V, Ruiz-Albusac JM. Insulin in the brain: its pathophysiological implications for States related with central insulin resistance, type 2 diabetes and Alzheimer's disease. Front Endocrinol (Lausanne). 2014;5:161.","journal-title":"Front Endocrinol (Lausanne)"},{"issue":"1","key":"ref2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.52586\/S550","article-title":"Gut dysbiosis, insulin resistance and Alzheimer's disease: review of a novel approach to neurodegeneration","volume":"13","author":"Lazar E","year":"2021","unstructured":"Lazar E, Sherzai A, Adeghate J, Sherzai D. Gut dysbiosis, insulin resistance and Alzheimer's disease: review of a novel approach to neurodegeneration. Front Biosci (Schol Ed). 2021;13(1):17\u201329.","journal-title":"Front Biosci (Schol Ed)"},{"issue":"2","key":"ref3","doi-asserted-by":"crossref","first-page":"441","DOI":"10.3233\/JAD-190948","article-title":"PRKAG2 gene expression is elevated and its protein levels are associated with increased amyloid-\u03b2 accumulation in the Alzheimer\u2019s disease brain","volume":"74","author":"Bharadwaj P","year":"2020","unstructured":"Bharadwaj P, Martins RN. PRKAG2 gene expression is elevated and its protein levels are associated with increased amyloid-\u03b2 accumulation in the Alzheimer\u2019s disease brain. J Alzheimer\u2019s Disease. 2020;74(2):441\u20138.","journal-title":"J Alzheimer\u2019s Disease"},{"issue":"1","key":"ref4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1210\/clinem\/dgz020","article-title":"AMPK Subunits Harbor Largely Nonoverlapping Genetic Determinants for Body Fat Mass, Glucose Metabolism, and Cholesterol Metabolism","volume":"105","author":"Randrianarisoa E","year":"2020","unstructured":"Randrianarisoa E, Lehn-Stefan A, Krier J, B\u00f6hm A, Heni M, De Hrab\u011b M, et al. AMPK Subunits Harbor Largely Nonoverlapping Genetic Determinants for Body Fat Mass, Glucose Metabolism, and Cholesterol Metabolism. J Clin Endocrinol Metabolism. 2020;105(1):14\u201325.","journal-title":"J Clin Endocrinol Metabolism"},{"issue":"10","key":"ref5","doi-asserted-by":"crossref","first-page":"12629","DOI":"10.3390\/ijms131012629","article-title":"The role of glucose transporters in brain disease: diabetes and Alzheimer\u2019s disease","volume":"13","author":"Shah K","year":"2012","unstructured":"Shah K, DeSilva S, Abbruscato T. The role of glucose transporters in brain disease: diabetes and Alzheimer\u2019s disease. Int J Mol Sci. 2012;13(10):12629\u201355.","journal-title":"Int J Mol Sci"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"13872877251364906","DOI":"10.1177\/13872877251364906","article-title":"The expression of insulin signaling and N-methyl-D-aspartate receptor genes in areas of gray matter atrophy is associated with cognitive function in type 2 diabetes","author":"Kesler SR","year":"2025","unstructured":"Kesler SR, Cuevas H, Lewis KA, Franco-Rocha OY, Flowers E. The expression of insulin signaling and N-methyl-D-aspartate receptor genes in areas of gray matter atrophy is associated with cognitive function in type 2 diabetes. J Alzheimers Dis. 2025:13872877251364906.","journal-title":"J Alzheimers Dis"},{"issue":"4","key":"ref7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.bpsgos.2021.10.002","article-title":"Imaging Transcriptomics of Brain Disorders","volume":"2","author":"Arnatkeviciute A","year":"2022","unstructured":"Arnatkeviciute A, Fulcher BD, Bellgrove MA, Fornito A. Imaging Transcriptomics of Brain Disorders. Biol Psychiatry Glob Open Sci. 2022;2(4):319\u201331.","journal-title":"Biol Psychiatry Glob Open Sci"},{"issue":"13","key":"ref8","doi-asserted-by":"crossref","first-page":"110173","DOI":"10.1016\/j.celrep.2021.110173","article-title":"Imaging transcriptomics: Convergent cellular, transcriptomic, and molecular neuroimaging signatures in the healthy adult human brain","volume":"37","author":"Martins D","year":"2021","unstructured":"Martins D, Giacomel A, Williams SCR, Turkheimer F, Dipasquale O, Veronese M, et al. Imaging transcriptomics: Convergent cellular, transcriptomic, and molecular neuroimaging signatures in the healthy adult human brain. Cell Rep. 2021;37(13):110173.","journal-title":"Cell Rep"},{"issue":"Database issue","key":"ref9","first-page":"D996","article-title":"Allen Brain Atlas: an integrated spatio-temporal portal for exploring the central nervous system","volume":"41","author":"Sunkin SM","year":"2013","unstructured":"Sunkin SM, Ng L, Lau C, Dolbeare T, Gilbert TL, Thompson CL, et al. Allen Brain Atlas: an integrated spatio-temporal portal for exploring the central nervous system. Nucleic Acids Res. 2013;41(Database issue):D996\u20131008.","journal-title":"Nucleic Acids Res"},{"issue":"9","key":"ref10","first-page":"2755","article-title":"Molecular properties underlying regional vulnerability to Alzheimer's disease pathology","volume":"141","author":"Grothe MJ","year":"2018","unstructured":"Grothe MJ, Sepulcre J, Gonzalez-Escamilla G, Jelistratova I, Scholl M, Hansson O, et al. Molecular properties underlying regional vulnerability to Alzheimer's disease pathology. Brain. 2018;141(9):2755\u201371.","journal-title":"Brain"},{"issue":"1","key":"ref11","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s13195-020-00674-7","article-title":"Analysis of brain region-specific co-expression networks reveals clustering of established and novel genes associated with Alzheimer disease","volume":"12","author":"Lancour D","year":"2020","unstructured":"Lancour D, Dupuis J, Mayeux R, Haines JL, Pericak-Vance MA, Schellenberg GC, et al. Analysis of brain region-specific co-expression networks reveals clustering of established and novel genes associated with Alzheimer disease. Alzheimers Res Ther. 2020;12(1):1\u201311.","journal-title":"Alzheimers Res Ther"},{"issue":"Suppl 2","key":"ref12","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s12920-022-01260-6","article-title":"Identifying Alzheimer\u2019s genes via brain transcriptome mapping","volume":"15","author":"Baik JY","year":"2022","unstructured":"Baik JY, Kim M, Bao J, Long Q, Shen L, Initiative ADN. Identifying Alzheimer\u2019s genes via brain transcriptome mapping. BMC Med Genom. 2022;15(Suppl 2):116.","journal-title":"BMC Med Genom"},{"issue":"2","key":"ref13","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1111\/jon.12827","article-title":"Imaging transcriptomics in neurodegenerative diseases","volume":"31","author":"Mroczek M","year":"2021","unstructured":"Mroczek M, Desouky A, Sirry W. Imaging transcriptomics in neurodegenerative diseases. J Neuroimaging. 2021;31(2):244\u201350.","journal-title":"J Neuroimaging"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.neuroscience.2025.01.053","article-title":"Associations between morphometric similarity network and brain gene expression in type 2 diabetes mellitus","volume":"572","author":"Liu Q","year":"2025","unstructured":"Liu Q, Du X, Zhang Y, Ding H, Qin W, Zhang Q. Associations between morphometric similarity network and brain gene expression in type 2 diabetes mellitus. Neuroscience. 2025;572:84\u201392.","journal-title":"Neuroscience"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1290231","DOI":"10.3389\/fnagi.2023.1290231","article-title":"Association between gene expression and altered resting-state functional networks in type 2 diabetes","volume":"15","author":"Zhang Y","year":"2023","unstructured":"Zhang Y, Du X, Qin W, Fu Y, Wang Z, Zhang Q. Association between gene expression and altered resting-state functional networks in type 2 diabetes. Front Aging Neurosci. 2023;15:1290231.","journal-title":"Front Aging Neurosci"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"118","DOI":"10.3389\/fnagi.2017.00118","article-title":"Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease","volume":"9","author":"Mullins RJ","year":"2017","unstructured":"Mullins RJ, Diehl TC, Chia CW, Kapogiannis D. Insulin Resistance as a Link between Amyloid-Beta and Tau Pathologies in Alzheimer's Disease. Front Aging Neurosci. 2017;9:118.","journal-title":"Front Aging Neurosci"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1590627","DOI":"10.3389\/fcell.2025.1590627","article-title":"Genetic mechanisms of hemispheric functional connectivity in diabetic retinopathy: a joint neuroimaging and transcriptomic study","volume":"13","author":"Huang X","year":"2025","unstructured":"Huang X, He YX, Wan S. Genetic mechanisms of hemispheric functional connectivity in diabetic retinopathy: a joint neuroimaging and transcriptomic study. Front Cell Dev Biol. 2025;13:1590627.","journal-title":"Front Cell Dev Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"132","DOI":"10.3389\/fpsyt.2014.00132","article-title":"Attempted and successful compensation in preclinical and early manifest neurodegeneration - a review of task FMRI studies","volume":"5","author":"Scheller E","year":"2014","unstructured":"Scheller E, Minkova L, Leitner M, Kloppel S. Attempted and successful compensation in preclinical and early manifest neurodegeneration - a review of task FMRI studies. Front Psychiatry. 2014;5:132.","journal-title":"Front Psychiatry"},{"issue":"1","key":"ref19","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000115751","article-title":"The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics","volume":"30","author":"Roberts RO","year":"2008","unstructured":"Roberts RO, Geda YE, Knopman DS, Cha RH, Pankratz VS, Boeve BF, et al. The Mayo Clinic Study of Aging: design and sampling, participation, baseline measures and sample characteristics. Neuroepidemiology. 2008;30(1):58\u201369.","journal-title":"Neuroepidemiology"},{"issue":"8","key":"ref20","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1002\/gps.4900","article-title":"Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population-based Mayo Clinic Study of Aging","volume":"33","author":"Wennberg AMV","year":"2018","unstructured":"Wennberg AMV, Hagen CE, Edwards K, Roberts RO, Machulda MM, Knopman DS, et al. Association of antidiabetic medication use, cognitive decline, and risk of cognitive impairment in older people with type 2 diabetes: Results from the population-based Mayo Clinic Study of Aging. Int J Geriatr Psychiatry. 2018;33(8):1114\u201320.","journal-title":"Int J Geriatr Psychiatry"},{"issue":"4","key":"ref21","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1001\/jamaneurol.2015.4756","article-title":"Decline in Weight and Incident Mild Cognitive Impairment: Mayo Clinic Study of Aging","volume":"73","author":"Alhurani RE","year":"2016","unstructured":"Alhurani RE, Vassilaki M, Aakre JA, Mielke MM, Kremers WK, Machulda MM, et al. Decline in Weight and Incident Mild Cognitive Impairment: Mayo Clinic Study of Aging. JAMA Neurol. 2016;73(4):439\u201346.","journal-title":"JAMA Neurol"},{"issue":"5","key":"ref22","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1001\/archneurol.2011.3029","article-title":"Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging","volume":"69","author":"Whitwell JL","year":"2012","unstructured":"Whitwell JL, Wiste HJ, Weigand SD, Rocca WA, Knopman DS, Roberts RO, et al. Comparison of imaging biomarkers in the Alzheimer Disease Neuroimaging Initiative and the Mayo Clinic Study of Aging. Arch Neurol. 2012;69(5):614\u201322.","journal-title":"Arch Neurol"},{"author":"Kurth F","key":"ref23","unstructured":"Kurth F, Luders E, Gaser C. Voxel-Based Morphometry. Brain Mapping2015. pp. 345\u20139."},{"issue":"7416","key":"ref24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/nature11405","article-title":"An anatomically comprehensive atlas of the adult human brain transcriptome","volume":"489","author":"Hawrylycz MJ","year":"2012","unstructured":"Hawrylycz MJ, Lein ES, Guillozet-Bongaarts AL, Shen EH, Ng L, Miller JA, et al. An anatomically comprehensive atlas of the adult human brain transcriptome. Nature. 2012;489(7416):391\u20139.","journal-title":"Nature"},{"issue":"2","key":"ref25","doi-asserted-by":"crossref","first-page":"e0148744","DOI":"10.1371\/journal.pone.0148744","article-title":"MENGA: A New Comprehensive Tool for the Integration of Neuroimaging Data and the Allen Human Brain Transcriptome Atlas","volume":"11","author":"Rizzo G","year":"2016","unstructured":"Rizzo G, Veronese M, Expert P, Turkheimer FE, Bertoldo A. MENGA: A New Comprehensive Tool for the Integration of Neuroimaging Data and the Allen Human Brain Transcriptome Atlas. PLoS ONE. 2016;11(2):e0148744.","journal-title":"PLoS ONE"},{"issue":"21","key":"ref26","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1002\/sim.9505","article-title":"Generalized additive models to analyze nonlinear trends in biomedical longitudinal data using R: Beyond repeated measures ANOVA and linear mixed models","volume":"41","author":"Mundo AI","year":"2022","unstructured":"Mundo AI, Tipton JR, Muldoon TJ. Generalized additive models to analyze nonlinear trends in biomedical longitudinal data using R: Beyond repeated measures ANOVA and linear mixed models. Stat Med. 2022;41(21):4266\u201383.","journal-title":"Stat Med"},{"issue":"3","key":"ref27","first-page":"297","article-title":"Generalized additive models","volume":"1","author":"Hastie T","year":"1986","unstructured":"Hastie T, Tibshirani R. Generalized additive models. Stat Sci. 1986;1(3):297\u2013310.","journal-title":"Stat Sci"},{"issue":"1","key":"ref28","doi-asserted-by":"crossref","first-page":"6215","DOI":"10.1038\/s41598-024-55850-8","article-title":"Mapping the spatial disparities of HIV prevalence in Ethiopian zones using the generalized additive model","volume":"14","author":"Yilema SA","year":"2024","unstructured":"Yilema SA, Shiferaw YA, Belay AT, Belay DB. Mapping the spatial disparities of HIV prevalence in Ethiopian zones using the generalized additive model. Sci Rep. 2024;14(1):6215.","journal-title":"Sci Rep"},{"issue":"11","key":"ref29","doi-asserted-by":"crossref","first-page":"4266","DOI":"10.1210\/en.2016-1524","article-title":"Nervous System Expression of PPAR\u03b3 and Mutant PPAR\u03b3 Has Profound Effects on Metabolic Regulation and Brain Development","volume":"157","author":"Stump M","year":"2016","unstructured":"Stump M, Guo D-F, Lu K-T, Mukohda M, Cassell MD, Norris AW, et al. Nervous System Expression of PPAR\u03b3 and Mutant PPAR\u03b3 Has Profound Effects on Metabolic Regulation and Brain Development. Endocrinology. 2016;157(11):4266\u201375.","journal-title":"Endocrinology"},{"issue":"1","key":"ref30","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1186\/s12868-017-0387-7","article-title":"PPAR\u03b3 coactivator-1\u03b1 (PGC-1\u03b1) protects neuroblastoma cells against amyloid-beta (A\u03b2) induced cell death and neuroinflammation via NF-\u03baB pathway","volume":"18","author":"Zhang Y","year":"2017","unstructured":"Zhang Y, Chen C, Jiang Y, Wang S, Wu X, Wang K. PPAR\u03b3 coactivator-1\u03b1 (PGC-1\u03b1) protects neuroblastoma cells against amyloid-beta (A\u03b2) induced cell death and neuroinflammation via NF-\u03baB pathway. BMC Neurosci. 2017;18(1):69.","journal-title":"BMC Neurosci"},{"issue":"3","key":"ref31","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1007\/s12035-018-1195-5","article-title":"Hyperglycemia-driven neuroinflammation compromises BBB leading to memory loss in both diabetes mellitus (DM) type 1 and type 2 mouse models","volume":"56","author":"Rom S","year":"2019","unstructured":"Rom S, Zuluaga-Ramirez V, Gajghate S, Seliga A, Winfield M, Heldt NA, et al. Hyperglycemia-driven neuroinflammation compromises BBB leading to memory loss in both diabetes mellitus (DM) type 1 and type 2 mouse models. Mol Neurobiol. 2019;56(3):1883\u201396.","journal-title":"Mol Neurobiol"},{"issue":"6","key":"ref32","doi-asserted-by":"crossref","DOI":"10.1097\/FJC.0000000000000143","article-title":"Activation of PPAR-\u03b3 by Pioglitazone Attenuates Oxidative Stress in Aging Rat Cerebral Arteries Through Upregulating UCP2","volume":"64","author":"Wang P","year":"2014","unstructured":"Wang P, Li B, Cai G, Huang M, Jiang L, Pu J et al. Activation of PPAR-\u03b3 by Pioglitazone Attenuates Oxidative Stress in Aging Rat Cerebral Arteries Through Upregulating UCP2. J Cardiovasc Pharmacol. 2014;64(6).","journal-title":"J Cardiovasc Pharmacol"},{"issue":"2","key":"ref33","doi-asserted-by":"crossref","first-page":"109","DOI":"10.14336\/AD.2014.0305","article-title":"Metabolic syndrome, aging and involvement of oxidative stress","volume":"6","author":"Bonomini F","year":"2015","unstructured":"Bonomini F, Rodella LF, Rezzani R. Metabolic syndrome, aging and involvement of oxidative stress. Aging disease. 2015;6(2):109.","journal-title":"Aging disease"},{"issue":"3","key":"ref34","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.psyneuen.2011.07.005","article-title":"AMPK \u03b32 subunit gene PRKAG2 polymorphism associated with cognitive impairment as well as diabetes in old age","volume":"37","author":"Kim E","year":"2012","unstructured":"Kim E, Lee SH, Lee KS, Cheong H-K, Namkoong K, Hong CH, et al. AMPK \u03b32 subunit gene PRKAG2 polymorphism associated with cognitive impairment as well as diabetes in old age. Psychoneuroendocrinology. 2012;37(3):358\u201365.","journal-title":"Psychoneuroendocrinology"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"e73138","DOI":"10.7554\/eLife.73138","article-title":"Type 2 diabetes mellitus accelerates brain aging and cognitive decline: Complementary findings from UK Biobank and meta-analyses","volume":"11","author":"Antal B","year":"2022","unstructured":"Antal B, McMahon LP, Sultan SF, Lithen A, Wexler DJ, Dickerson B, et al. Type 2 diabetes mellitus accelerates brain aging and cognitive decline: Complementary findings from UK Biobank and meta-analyses. eLife. 2022;11:e73138.","journal-title":"eLife"},{"issue":"10","key":"ref36","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.2337\/dc24-0860","article-title":"Diabetes, Prediabetes, and Brain Aging: The Role of Healthy Lifestyle","volume":"47","author":"Dove A","year":"2024","unstructured":"Dove A, Wang J, Huang H, Dunk MM, Sakakibara S, Guitart-Masip M, et al. Diabetes, Prediabetes, and Brain Aging: The Role of Healthy Lifestyle. Diabetes Care. 2024;47(10):1794\u2013802.","journal-title":"Diabetes Care"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"2919","DOI":"10.2147\/DDDT.S367229","article-title":"Protective Effects of Pioglitazone on Cognitive Impairment and the Underlying Mechanisms: A Review of Literature","volume":"16","author":"Alhowail A","year":"2022","unstructured":"Alhowail A, Alsikhan R, Alsaud M, Aldubayan M, Rabbani SI. Protective Effects of Pioglitazone on Cognitive Impairment and the Underlying Mechanisms: A Review of Literature. Drug Des Devel Ther. 2022;16:2919\u201331.","journal-title":"Drug Des Devel Ther"},{"issue":"2","key":"ref38","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1016\/j.pbb.2011.08.020","article-title":"Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats","volume":"100","author":"Sharma B","year":"2011","unstructured":"Sharma B, Singh N. Behavioral and biochemical investigations to explore pharmacological potential of PPAR-gamma agonists in vascular dementia of diabetic rats. Pharmacol Biochem Behav. 2011;100(2):320\u20139.","journal-title":"Pharmacol Biochem Behav"},{"issue":"1","key":"ref39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s40266-014-0228-7","article-title":"Peroxisome proliferator-activated receptor-gamma agonists for Alzheimer's disease and amnestic mild cognitive impairment: a systematic review and meta-analysis","volume":"32","author":"Liu J","year":"2015","unstructured":"Liu J, Wang LN, Jia JP. Peroxisome proliferator-activated receptor-gamma agonists for Alzheimer's disease and amnestic mild cognitive impairment: a systematic review and meta-analysis. Drugs Aging. 2015;32(1):57\u201365.","journal-title":"Drugs Aging"},{"issue":"11","key":"ref40","first-page":"950","article-title":"Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study","volume":"13","author":"Watson GS","year":"2005","unstructured":"Watson GS, Cholerton BA, Reger MA, Baker LD, Plymate SR, Asthana S, et al. Preserved cognition in patients with early Alzheimer disease and amnestic mild cognitive impairment during treatment with rosiglitazone: a preliminary study. Am J Geriatr Psychiatry. 2005;13(11):950\u20138.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"5","key":"ref41","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000510677","article-title":"Antidiabetic Drugs in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review","volume":"49","author":"Mu\u00f1oz-Jim\u00e9nez M","year":"2020","unstructured":"Mu\u00f1oz-Jim\u00e9nez M, Zaarkti A, Garc\u00eda-Arn\u00e9s JA, Garc\u00eda-Casares N. Antidiabetic Drugs in Alzheimer's Disease and Mild Cognitive Impairment: A Systematic Review. Dement Geriatr Cogn Disord. 2020;49(5):423\u201334.","journal-title":"Dement Geriatr Cogn Disord"},{"issue":"4","key":"ref42","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s12640-013-9437-9","article-title":"Role of nuclear receptor on regulation of BDNF and neuroinflammation in hippocampus of \u03b2-amyloid animal model of Alzheimer's disease","volume":"25","author":"Prakash A","year":"2014","unstructured":"Prakash A, Kumar A. Role of nuclear receptor on regulation of BDNF and neuroinflammation in hippocampus of \u03b2-amyloid animal model of Alzheimer's disease. Neurotox Res. 2014;25(4):335\u201347.","journal-title":"Neurotox Res"},{"issue":"1","key":"ref43","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.tips.2023.11.004","article-title":"PPAR agonists for the treatment of neuroinflammatory diseases","volume":"45","author":"Titus C","year":"2024","unstructured":"Titus C, Hoque MT, Bendayan R. PPAR agonists for the treatment of neuroinflammatory diseases. Trends Pharmacol Sci. 2024;45(1):9\u201323.","journal-title":"Trends Pharmacol Sci"},{"issue":"9","key":"ref44","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/nm.2421","article-title":"Peroxisome proliferation\u2013associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity","volume":"17","author":"Diano S","year":"2011","unstructured":"Diano S, Liu Z-W, Jeong JK, Dietrich MO, Ruan H-B, Kim E, et al. Peroxisome proliferation\u2013associated control of reactive oxygen species sets melanocortin tone and feeding in diet-induced obesity. Nat Med. 2011;17(9):1121\u20137.","journal-title":"Nat Med"},{"issue":"7","key":"ref45","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1152\/physiolgenomics.00032.2016","article-title":"Effect of selective expression of dominant-negative PPAR\u03b3 in pro-opiomelanocortin neurons on the control of energy balance","volume":"48","author":"Stump M","year":"2016","unstructured":"Stump M, Guo DF, Lu KT, Mukohda M, Liu X, Rahmouni K, et al. Effect of selective expression of dominant-negative PPAR\u03b3 in pro-opiomelanocortin neurons on the control of energy balance. Physiol Genomics. 2016;48(7):491\u2013501.","journal-title":"Physiol Genomics"},{"issue":"1","key":"ref46","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s40364-021-00317-5","article-title":"Circulating MicroRNAs predict glycemic improvement and response to a behavioral intervention","volume":"9","author":"Flowers E","year":"2021","unstructured":"Flowers E, Allen IE, Kanaya AM, Aouizerat BE. Circulating MicroRNAs predict glycemic improvement and response to a behavioral intervention. Biomark Res. 2021;9(1):65.","journal-title":"Biomark Res"},{"issue":"D1","key":"ref47","doi-asserted-by":"crossref","first-page":"D147","DOI":"10.1093\/nar\/gkae1072","article-title":"miRTarBase 2025: updates to the collection of experimentally validated microRNA-target interactions","volume":"53","author":"Cui S","year":"2025","unstructured":"Cui S, Yu S, Huang HY, Lin YC, Huang Y, Zhang B, et al. miRTarBase 2025: updates to the collection of experimentally validated microRNA-target interactions. Nucleic Acids Res. 2025;53(D1):D147\u201356.","journal-title":"Nucleic Acids Res"},{"issue":"11","key":"ref48","doi-asserted-by":"crossref","DOI":"10.3390\/ijms25115684","article-title":"MicroRNAs Associated with Metformin Treatment in the Diabetes Prevention Program","volume":"25","author":"Lewis KA","year":"2024","unstructured":"Lewis KA, Stroebel BM, Zhang L, Aouizerat B, Mattis AN, Flowers E. MicroRNAs Associated with Metformin Treatment in the Diabetes Prevention Program. Int J Mol Sci. 2024;25(11).","journal-title":"Int J Mol Sci"},{"issue":"6","key":"ref49","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1007\/s11682-022-00710-0","article-title":"Compensatory thalamocortical functional hyperconnectivity in type 2 Diabetes Mellitus","volume":"16","author":"Wang J","year":"2022","unstructured":"Wang J, Zhou S, Deng D, Chen M, Cai H, Zhang C, et al. Compensatory thalamocortical functional hyperconnectivity in type 2 Diabetes Mellitus. Brain Imaging Behav. 2022;16(6):2556\u201368.","journal-title":"Brain Imaging Behav"},{"key":"ref50","first-page":"14","article-title":"Topological Alterations of the Brain Functional Network in Type 2 Diabetes Mellitus Patients With and Without Mild Cognitive Impairment","author":"Zhou B","year":"2022","unstructured":"Zhou B, Wang X, Yang Q, Wu F, Tang L, Wang J et al. Topological Alterations of the Brain Functional Network in Type 2 Diabetes Mellitus Patients With and Without Mild Cognitive Impairment. Front Aging Neurosci. 2022;Volume 14\u20132022:834319.","journal-title":"Front Aging Neurosci"},{"issue":"16","key":"ref51","doi-asserted-by":"crossref","first-page":"8075","DOI":"10.3390\/ijms26168075","article-title":"AMP-Activated Protein Kinases in Health and Disease","volume":"26","author":"Kim HI","year":"2025","unstructured":"Kim HI, Han Y, Park J. AMP-Activated Protein Kinases in Health and Disease. Int J Mol Sci. 2025;26(16):8075.","journal-title":"Int J Mol Sci"},{"issue":"138","key":"ref52","doi-asserted-by":"crossref","DOI":"10.1098\/rsif.2017.0774","article-title":"Keeping the home fires burning: AMP-activated protein kinase","volume":"15","author":"Hardie DG","year":"2018","unstructured":"Hardie DG. Keeping the home fires burning: AMP-activated protein kinase. J R Soc Interface. 2018;15(138).","journal-title":"J R Soc Interface"},{"issue":"12","key":"ref53","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.1016\/j.celrep.2016.11.066","article-title":"Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis","volume":"17","author":"Hinson JT","year":"2016","unstructured":"Hinson JT, Chopra A, Lowe A, Sheng CC, Gupta RM, Kuppusamy R, et al. Integrative Analysis of PRKAG2 Cardiomyopathy iPS and Microtissue Models Identifies AMPK as a Regulator of Metabolism, Survival, and Fibrosis. Cell Rep. 2016;17(12):3292\u2013304.","journal-title":"Cell Rep"},{"issue":"14","key":"ref54","article-title":"Mitochondrial Function, and Cardiovascular Disease","volume":"21","author":"Wu S","year":"2020","unstructured":"Wu S, Zou M-HAMPK. Mitochondrial Function, and Cardiovascular Disease. Int J Mol Sci [Internet]. 2020; 21(14).","journal-title":"Int J Mol Sci [Internet]"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2147\/PGPM.S305020","article-title":"A two-stage study identifies two novel polymorphisms in PRKAG2 affecting metformin response in Chinese type 2 diabetes patients","author":"Xiao D","year":"2021","unstructured":"Xiao D, Liu J-Y, Zhang S-M, Liu R-R, Yin J-Y, Han X-Y et al. A two-stage study identifies two novel polymorphisms in PRKAG2 affecting metformin response in Chinese type 2 diabetes patients. Pharmacogenomics Personalized Med. 2021:745\u201355.","journal-title":"Pharmacogenomics Personalized Med"},{"issue":"15","key":"ref56","article-title":"Actions of Metformin in the Brain: A New Perspective of Metformin Treatments in Related Neurological Disorders","volume":"23","author":"Li N","year":"2022","unstructured":"Li N, Zhou T, Fei E. Actions of Metformin in the Brain: A New Perspective of Metformin Treatments in Related Neurological Disorders. Int J Mol Sci [Internet]. 2022; 23(15).","journal-title":"Int J Mol Sci [Internet]"},{"issue":"5","key":"ref57","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1159\/000510677","article-title":"Antidiabetic Drugs in Alzheimer\u2019s Disease and Mild Cognitive Impairment: A Systematic Review","volume":"49","author":"Mu\u00f1oz-Jim\u00e9nez M","year":"2020","unstructured":"Mu\u00f1oz-Jim\u00e9nez M, Zaarkti A, Garc\u00eda-Arn\u00e9s JA, Garc\u00eda-Casares N. Antidiabetic Drugs in Alzheimer\u2019s Disease and Mild Cognitive Impairment: A Systematic Review. Dement Geriatr Cogn Disord. 2020;49(5):423\u201334.","journal-title":"Dement Geriatr Cogn Disord"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7907793\/v1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7907793\/v1.html","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T01:54:07Z","timestamp":1762739647000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.researchsquare.com\/article\/rs-7907793\/v1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,22]]},"references-count":57,"URL":"https:\/\/doi.org\/10.21203\/rs.3.rs-7907793\/v1","relation":{},"subject":[],"published":{"date-parts":[[2025,10,22]]},"subtype":"preprint"}}